Mark V Rubertone
Affiliation: Walter Reed Army Medical Center
- Trends in overweight and obesity among 18-year-old applicants to the United States military, 1993-2006Lucy L Hsu
Army Medical Surveillance Activity, U S Army Center for Health Promotion and Preventive Medicine, Silver Spring, Maryland 20910, USA
J Adolesc Health 41:610-2. 2007..The prevalence of overweight increased from 22.8% in 1993 to 27.1% in 2006, and obesity increased from 2.8% to 6.8%. We conclude the U.S. military is recruiting from an increasingly overweight population...
- The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillanceMark V Rubertone
Army Medical Surveillance Activity, Directorate of Epidemiology and Disease Surveillance, US Army Center for Health Promotion and Preventive Medicine, Washington, DC 20307, USA
Am J Public Health 92:1900-4. 2002..Recent applications of the DMSS and DoDSR provide glimpses of the capabilities and uses of comprehensive public health surveillance systems...
- Comparing the population health impacts of medical conditions using routinely collected health care utilization data: nature and sources of variabilityJohn F Brundage
Army Medical Surveillance Activity, Epidemiology and Disease Surveillance Directorate, U S Army Center for Health Promotion and Preventive Medicine, Washington, DC 20307, USA
Mil Med 171:937-42. 2006..The findings are relevant to prevention planning and resourcing...
- Comprehensive systematic surveillance for adverse effects of anthrax vaccine adsorbed, US Armed Forces, 1998-2000Jeffrey L Lange
Army Medical Surveillance Activity, US Army Center for Health Promotion and Preventive Medicine, Building T 20, Room 213 Attn MCHB TS EDM, 6900 Georgia Avenue, NW, Washington, DC 20307 5001, USA
Vaccine 21:1620-8. 2003..This surveillance suggests that Anthrax Vaccine Adsorbed has few, if any, clinically significant adverse effects...
- Analysis of adverse events after anthrax immunization in US Army medical personnelGlenn M Wasserman
Preventive Medicine Department, Tripler Army Medical Center, Honolulu, Hawaii, USA
J Occup Environ Med 45:222-33. 2003..Our findings suggest that AVA is relatively reactogenic but do not indicate serious adverse health effects due to immunization...
- Timing and completeness of routine testing for antibodies to human immunodeficiency virus type 1 among active duty members of the U.S. Armed ForcesMichael J Silverberg
Army Medical Surveillance Activity, Walter Reed Army Medical Center, Washington, DC 20307, USA
Mil Med 168:160-4. 2003..The results of this analysis may inform the planning and conduct of human immunodeficiency virus type 1 prevention programs as well as deployment-related or other surveillance activities...
- Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnelDarrell E Singer
Division of Retrovirology, Walter Reed Army Institute of Research, Military HIV Research Program, Rockville, MD, USA
Vaccine 26:869-73. 2008..95 microg/mL and 45.5%, respectively. The forth dose elicited 100% seroconversion compared to the pre-immunization level. These results should facilitate comparison between different immunization schedules and new vaccines...
- Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosisLynn I Levin
Division of Preventive Medicine, Walter Reed Army Institute of Research, Silver Spring, MD, USA
JAMA 293:2496-500. 2005..Infection with Epstein-Barr virus (EBV) has been associated with an increased risk of multiple sclerosis (MS), but the temporal relationship remains unclear...
- Development of autoantibodies before the clinical onset of systemic lupus erythematosusMelissa R Arbuckle
Arthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA
N Engl J Med 349:1526-33. 2003..We investigated the onset and progression of autoantibody development before the clinical diagnosis...
- Genetic variation in the inhibin pathway and risk of testicular germ cell tumorsMark P Purdue
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, MD 20892, USA
Cancer Res 68:3043-8. 2008..89-2.99; TT: OR, 4.54; 95% CI 2.00-10.3; P(trend) = 0.0008). We found no evidence of association with variants in the other investigated genes. These findings suggest that genetic variation in the INHA locus influences TGCT development...